These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9098190)

  • 61. Comparison of differential diagnostic capabilities of 201Tl scintigraphy and fine-needle aspiration of thyroid nodules.
    Okumura Y; Takeda Y; Sato S; Komatsu M; Nakagawa T; Akaki S; Kuroda M; Joja I; Hiraki Y
    J Nucl Med; 1999 Dec; 40(12):1971-7. PubMed ID: 10616873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
    Hashimoto T; Goto K; Hishinuma Y; Yachuda K; Sugioka Y; Arai K; Harada S; Goto M
    Ann Nucl Med; 2000 Aug; 14(4):293-8. PubMed ID: 11023030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
    Tonami N; Itoh K; Yui N; Terui S; Torizuka K
    Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
    Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study.
    Tartagni F; Dondi M; Limonetti P; Franchi R; Maiello L; Monetti N; Magnani B
    J Nucl Med; 1991 Mar; 32(3):369-76. PubMed ID: 2005443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy.
    Söderlund V; Larsson SA; Bauer HC; Brosjö O; Larsson O; Jacobsson H
    Eur J Nucl Med; 1997 May; 24(5):511-5. PubMed ID: 9142731
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
    Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
    Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
    Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
    Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
    G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparative study of 201Tl and 99mTc-MIBI in breast tumor].
    Fukumitsu N; Tozaki M; Uchiyama M; Mori Y; Kawakami K; Uchida K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Nov; 56(13):974-9. PubMed ID: 8969062
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uptake kinetics of technetium-99m-methoxyisobutylisonitrile and thallium-201 in adult rat heart endothelial and fibroblast-like cells in comparison to myocytes.
    Caldwell JH; Mertens H; Linssen MC; van der Vusse GJ; Buell U; Kammermeier H
    J Nucl Med; 1992 Jan; 33(1):102-7. PubMed ID: 1530964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi.
    Kapucu LO; Akyüz C; Vural G; Oguz A; Atasever T; Büyükpamukçu M; Unlü M
    J Nucl Med; 1997 Feb; 38(2):243-7. PubMed ID: 9025746
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
    Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
    Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of the alteration uptake ratio of
    Huang Z; Lou C
    Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area.
    Kresnik E; Gallowitsch HJ; Mikosch P; Gomez I; Lind P
    J Nucl Med; 1997 Jan; 38(1):62-5. PubMed ID: 8998152
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
    Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
    Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Does (99m)Tc-Sestamibi in high-grade malignant brain tumors reflect blood-brain barrier damage only?
    Staudenherz A; Fazeny B; Marosi C; Nasel C; Hoffmann M; Puig S; Killer M; Leitha T
    Neuroimage; 2000 Jul; 12(1):109-11. PubMed ID: 10875907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.